Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel P Murray

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Indian Journal of Urology : IJU : Journal of the Urological Society of India|August 5, 2011
Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrolNigel P Murray, Leonardo V Badinez, Ricardo R Dueñas, et al.
Ecancermedicalscience|November 19, 2020
Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery aloneNigel P Murray, Socrates Aedo, Ricardo Villalon, et al.
Archivos Espanoles De Urologia|July 5, 2021
[CAPRA score vs minimal residual disease as predictors of biochemical recurrence after radical prostatectomy.]Nigel P Murray, Cinthia Fuentealba, Eduardo Reyes, et al.
Turkish Journal of Urology|May 14, 2020
The expression of matrix-metalloproteinase-2 in bone marrow micro-metastasis is associated with the presence of circulating prostate cells and a worse prognosis in men treated with radical prostatectomy for prostate cancerNigel P Murray, Eduardo Reyes, Anibal Salazar, et al.
Case Reports in Hematology|December 12, 2018
Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the LiteratureNigel P Murray, Cynthia Fuentealba, Isidora Salazar, et al.
Ecancermedicalscience|July 31, 2020
The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomyNigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Archivos Espanoles De Urologia|January 10, 2012
Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsyNigel P Murray, E Reyes, P Tapia, et al.
Ecancermedicalscience|June 23, 2020
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapyNigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Archivos Espanoles De Urologia|December 12, 2019
[Circulating prostate cells and bone marrow micro-metastasis and not treatment modality determine the risk and time to biochemical failure in low risk prostate cancer.]Nigel P Murray, Sócrates Aedo, Cynthia Fuentealba, et al.
Thescientificworldjournal|May 9, 2013
Secondary circulating prostate cells predict biochemical failure in prostate cancer patients after radical prostatectomy and without evidence of diseaseNigel P Murray, Eduardo Reyes, Nelson Orellana, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Indian Journal of Urology : IJU : Journal of the Urological Society of India|August 5, 2011
Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrolNigel P Murray, Leonardo V Badinez, Ricardo R Dueñas, et al.
Ecancermedicalscience|November 19, 2020
Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery aloneNigel P Murray, Socrates Aedo, Ricardo Villalon, et al.
Archivos Espanoles De Urologia|July 5, 2021
[CAPRA score vs minimal residual disease as predictors of biochemical recurrence after radical prostatectomy.]Nigel P Murray, Cinthia Fuentealba, Eduardo Reyes, et al.
Turkish Journal of Urology|May 14, 2020
The expression of matrix-metalloproteinase-2 in bone marrow micro-metastasis is associated with the presence of circulating prostate cells and a worse prognosis in men treated with radical prostatectomy for prostate cancerNigel P Murray, Eduardo Reyes, Anibal Salazar, et al.
Case Reports in Hematology|December 12, 2018
Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the LiteratureNigel P Murray, Cynthia Fuentealba, Isidora Salazar, et al.
Ecancermedicalscience|July 31, 2020
The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomyNigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Archivos Espanoles De Urologia|January 10, 2012
Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsyNigel P Murray, E Reyes, P Tapia, et al.
Ecancermedicalscience|June 23, 2020
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapyNigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Archivos Espanoles De Urologia|December 12, 2019
[Circulating prostate cells and bone marrow micro-metastasis and not treatment modality determine the risk and time to biochemical failure in low risk prostate cancer.]Nigel P Murray, Sócrates Aedo, Cynthia Fuentealba, et al.
Thescientificworldjournal|May 9, 2013
Secondary circulating prostate cells predict biochemical failure in prostate cancer patients after radical prostatectomy and without evidence of diseaseNigel P Murray, Eduardo Reyes, Nelson Orellana, et al.
Pageof 8